CanariaBio and Hikma announce the signing of distribution and license agreement for oregovomab in MENA Region

By /

CanariaBio Inc. and Hikma MENA FZE, part of Hikma Pharmaceuticals PLC, announced the signing of distribution and license agreement for oregovomab in the Middle East and North Africa region.

Scroll to Top